Eleana Hardy
Head, Global Independent Medical Education, Investigator Sponsored Trials & US Expanded Access Program Jazz Pharmaceuticals plc
Eleana Hardy is Director at Jazz Pharmaceuticals, where she leads patient and medical education strategy and communications. With extensive experience in medical affairs and strategic program development, Eleana has a proven track record of designing impactful educational initiatives across the pharmaceutical sector. Previously, she served as Associate Director of Medical Education at Regeneron Pharmaceuticals and held key roles in strategic grants management at Verastem Oncology and Shire Pharmaceuticals, supporting global healthcare initiatives. Eleana?s career also includes leadership positions at Biogen, SmithBucklin, and early roles at the University of North Carolina at Chapel Hill and GSK, demonstrating a broad expertise in program management, medical education, and strategic analysis.
Seminars
- Anticipating patient needs and country-specific timelines to maintain uninterrupted access during program closure or handover
- Aligning internal teams, local stakeholders, and advocacy groups to address operational, regulatory, and financial challenges
- Learning from real-world multi-country cases to optimize transition planning and avoid common pitfalls
